未登录Donanemab in Early Symptomatic Alzheimer Disease The TRAILBLAZER-ALZ 2 Randomized Clinical TrialDonanemab在早期症状性阿尔茨海默病中的开拓者-ALZ 2随机临床试验
Sims, John R.; Zimmer, Jennifer A.; Evans, Cynthia D.; Lu, Ming; Ardayfio, Paul; Sparks, JonDavid; Wessels, Alette M.; Shcherbinin, Sergey; Wang, Hong; Nery, Emel Serap Monkul; Collins, Emily C.; Solomon, Paul; Salloway, Stephen; Apostolova, Liana G.; Hansson, Oskar; Ritchie, Craig; Brooks, Dawn A.; Mintun, Mark; Skovronsky, Daniel M.
分享
收藏Intepirdine as adjunctive therapy to donepezil for mild-to-moderate Alzheimer's disease: A randomized, placebo-controlled, phase 3 clinical trial (MINDSET)
Lang, Frederick M.; Mo, Yi; Sabbagh, Marwan; Solomon, Paul; Boada, Merce; Jones, Roy W.; Frisoni, Giovanni B.; Grimmer, Timo; Dubois, Bruno; Harnett, Mark; Friedhoff, Sarah R.; Coslett, Shari; Cummings, Jeffrey L.
分享
收藏
分享
收藏A randomized, double-blind, placebo controlled, parallel group, efficacy study of alpha BRAIN® administered orally
Solomon, Todd M.; Leech, Jarrett; deBros, Guy B.; Murphy, Cynthia A.; Budson, Andrew E.; Vassey, Elizabeth A.; Solomon, Paul R.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏